Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,209.01
+1.0%
+73.06
Arrow-Thin-Down
DJI
49,652.14
+1.6%
+790.33
Arrow-Thin-Down
NASDAQ
24,892.31
+0.9%
+219.07
Arrow-Thin-Down
Bitcoin
$77,569.00
+1.8%
+$1,392.77
Arrow-Thin-Down
AAPL
$271.35
+0.4%
+$1.18
Arrow-Thin-Down
AMZN
$265.06
+0.8%
+$2.02
Arrow-Thin-Down
GOOG
$382.04
+10.0%
+$34.73
Arrow-Thin-Down
META
$612.31
-8.5%
-$56.81
Arrow-Thin-Down
MSFT
$407.91
-3.9%
-$16.55
Arrow-Thin-Down
NVDA
$199.98
-4.4%
-$9.27
Arrow-Thin-Down
TSLA
$381.92
+2.4%
+$9.12
Most Active StocksDaily Stock GainersDaily Stock Losers

InhaleRx Ltd

(ASX) NX1

Current Price$0.02
Market Cap$5.57M
Since IPO (2017)-94%
5 Year-78%
1 Year-12%
1 Month+29%

InhaleRx Ltd Financials at a Glance

Market Cap

$5.57M

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$-0.01

P/E Ratio

-2.93

Dividend

$0.00

Beta (Volatility)

0.20 (Low)

Price

$0.02

Volume

140,000

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.02 - $0.05

NX1 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About InhaleRx Ltd

Industry

Healthcare Equipment and Supplies

Sector

Health Care

CEO

Darryl Davies

Website

www.inhalerx.com.au

NX1 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-34.13%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$5.57M

Shares Outstanding

253.04M

Volume

140.00K

Avg. Volume

89.66K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

InhaleRx Ltd Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

$5.57M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Net Cash

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7198.60+0.01%
^DJIDJI
$49643.60+0.02%
^IXICNASDAQ
$24866.43+0.01%
BTCBitcoin
$76257.00+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$63.54+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.47+0.05%
NOKNokia
$12.91+0.04%
NVDANvidia
$199.57-0.05%

Questions About NX1

What is the current price of InhaleRx Ltd?

InhaleRx Ltd is trading at A$0.02 per share.

What is the 52-week range for InhaleRx Ltd?

Over the past 52 weeks, InhaleRx Ltd has traded between A$0.02 and A$0.05.

How much debt does InhaleRx Ltd have?

As of the most recent reporting period, InhaleRx Ltd reported total debt of $741,278.

How much cash does InhaleRx Ltd have on hand?

InhaleRx Ltd reported $436,900 in cash and cash equivalents in its most recent financial results.

What is InhaleRx Ltd’s dividend yield?

InhaleRx Ltd does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services